CME webinars guide clinicians who manage diabetes patients during COVID-19 pandemic

Multiple studies have shown that patients with diabetes are at increased risk of developing COVID-19 and suffering severe symptoms. As knowledge about the pathophysiology of COVID-19 continues to evolve, recent figures from the Centers for Disease Control and Prevention (CDC) indicate that 13 percent of the adult U.S. population has diabetes — 34 million Americans who face a greater risk of both acquiring COVID-19 and requiring hospitalization to treat serious complications. To help clinicians remain current and manage their patients with diabetes during the pandemic, Rockpointe, a leading continuing medical education provider, along with a collaboration of 20 state medical societies and the Potomac Center for Medical Education offer the latest guidance during three live CME/CE-certified, MOC-eligible webinars (Nov. 2, Nov. 10, and Dec. 2).

Diabetes and COVID-19 in the Outpatient Setting: What Clinicians Need to Know is an hour-long program geared toward clinicians responsible for the daily management of patients with diabetes. Participants will receive the most up-to-date information to help them appropriately advise their patients on how to avoid infection, monitor patients who develop COVID-19, and recognize and manage complications as they occur to minimize morbidity and mortality. Faculty will discuss the pathophysiology of COVID-19 and factors that increase risks for patients with diabetes, then turn to strategies for managing diabetes patients during the pandemic, followed by a Q&A session.

Dates and Times

Monday, November 2, 2020
4:00 – 5:00 PM ET (3:00 – 4:00 PM CT / 1:00 – 2:00 PM PT)

Tuesday, November 10, 2020
7:00 – 8:00 PM ET (6:00 – 7:00 PM CT / 4:00 – 5:00 PM PT)

Wednesday, December 2, 2020
1:00 – 2:00 PM ET (12:00 – 1:00 PM CT / 10:00 – 11:00 AM PT)

This free educational initiative is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine; and to address ACPE competencies, including foundational knowledge and essentials for practice and care. At the program’s conclusion, participants should be able to:

  • Discuss the most current understanding of the pathophysiology of COVID-19.
  • Describe factors that increase the risk of COVID-19 for patients with diabetes.
  • Integrate recommendations for the safe and effective management of patients with diabetes during the COVID-19 pandemic.
  • Provide counsel to patients with diabetes regarding concerns or fears related to COVID-19.

“Diabetes patients are some of the vulnerable to this pandemic.  We believe this series will allow clinicians to successfully manage COVID-19 patients with diabetes.”  Thomas Sullivan, CEO Rockpointe

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education (PCME) and Rockpointe. PCME, which is accredited by the ACCME to provide continuing medical education for physicians, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.

Successful completion of this CME activity, which includes participation in the evaluation component, enables participants to earn up to 1.0 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

PCME is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education and designates this knowledge- and practice-based activity for a maximum of 1.0 contact hour (0.10 CEU) of continuing education credit.

There is no fee for this activity, which is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Lilly USA, and Merck. To receive credit, participants must register, view the live CME/CE activity in its entirety, and then complete the post-test, with a score of 75% or better, and evaluation. The estimated time for completion of this activity is one hour. To receive a certificate, participants must demonstrate mastery of the presented material via the post-test. Participants are allowed to take the post-test multiple times.

Through effective continuing medical education, Rockpointe strives to improve and advance the quality of patient care. Its educational programs have been at the forefront of new issues in healthcare, such as managing challenges posed by COVID-19, addressing racial disparities in care, and combating the nation’s opioid crisis.   Additional available courses for COVID-19 include Obesity, Lung Cancer, Clinical Management, and Asthma and Telemedicine.

As part of its commitment to quality, Rockpointe works to inform the continuing-education community of significant quality-improvement issues through news and analysis on Policy and Medicine. In addition, its popular Medical Education Exchange (MEDX) CME regional meetings include sessions on the basics of quality improvement and alternative payment models, as well as relevant and scientifically accurate sessions on numerous disease states. All sessions include links back to associated National Quality Priorities to reinforce the bigger picture and the triple aim of: 1) improving health and 2) lowering cost to 3) better the patient experience. At Rockpointe, education equals quality.

For session times and to register for Diabetes and COVID-19 in the Outpatient Setting, go to  or click here.


For more COVID-19 CME programs, click here.


About Rockpointe

Through effective continuing medical education (CME), PCME parent company Rockpointe strives to improve and advance the quality of patient care. Its educational programs have been at the forefront of new issues in healthcare, including implementing MACRA, combating the nation’s opioid and vaping crises, and providing timely, accessible COVID-19 education and resources to healthcare providers. Rockpointe has been a leading CME provider for 25 years.

Leave a Reply

Your email address will not be published.

Follow Us :

Follow Us :

© 2021 Rockpointe Corporation

Privacy Policy

© 2021 Rockpointe Corporation

Privacy Policy